Li S, Zhang Z Q, Wu L J, et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network[J]. IET Syst Biol, 2007,1(1):51.
[2]
Prado-Prado F J, Uriarte E, Borges F, et al. Multi-target spectral moments for QSAR and complex networks study of antibacterial drugs[J]. Eur J Med Chem, 2009,44(11):4516.
[3]
Wishart D S. Discovering drug targets through the web[J]. Comp Biochem Physiol Part D Genomics Proteomics, 2007,2(1):9.
[4]
Yao X, Hao H, Li Y, et al. Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network[J].BMC Syst Biol, 2011,5(1):79.
[5]
Zhao J, Jiang P, Zhang W. Molecular networks for the study of TCM Pharmacology[J]. Brief Bioinform, 2010,11(4):417.
[6]
Hughes B. FDA drug approvals [J]. Nat Rev Drug Discov, 2008, 8:93.
[7]
Hopkins A L. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol, 2008, 4(11): 682.
[8]
Hopkins A L. Network pharmacology [J]. Nat Biotechnol, 2007, 25(10): 1110.
[9]
Keshava Prasad T S, Goel R, Kandasamy K, et al. Human protein reference database—2009 update[J]. Nucleic Acids Res, 2009,37(1):D767.
[10]
Bader G D, Betel D, Hogue C W V. BIND: the biomolecular interaction network database[J]. Nucleic Acids Res, 2003,31(1):248.
[11]
Alfarano C, Andrade C E, Anthony K, et al. The biomolecular interaction network database and related tools 2005 update[J]. Nucleic Acids Res, 2005,33(1):D418.
[12]
Xenarios I, Salwinski L, Duan X J, et al. DIP, the Database of interacting proteins: a research tool for studying cellular networks of protein interactions[J]. Nucleic Acids Res, 2002,30(1):303.
[13]
Hamosh A, Scott A F, Amberger J S, et al. Online mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders[J]. Nucleic Acids Res, 2005,33(1):D514.
[14]
Knox C, Law V, Jewison T, et al. DrugBank 3.0: a comprehensive resource for \'Omics’ research on drugs[J].Nucleic Acids Res, 2011,39(1):D1035.
[15]
Aurray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare [J]. Genome Med, 2009, 1(1):2.
[16]
Ma T, Tan C, Zhang H, et al. Bridging the gap between traditional Chinese medicine and systems biology: the connection of cold syndrome and NEI network [J]. Mol BioSyst, 2010, 6(4): 613.
Tong Lu, Junling Yang, Xiumei Gao, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine [J]. Drug Metab Dispos, 2008, 36(1):1578.
[19]
Lipinski C A, Lombardo F, Dominy B W, et al. Experimental estimation of the effective unstirred water layer thickness in the human jejunum and its importance in oral drug absorption [J]. Adv Drug Delivery Rev, 1997, 23(1/3): 3.
[20]
Ekins S, Rose J. In silico ADME/ Tox : the state of the art[J]. J Mol Graph Mod, 2002, 20(4) :305 .
[21]
Cruciani G, Pastor M, Guba W. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds [J]. Eur J Pharm Sci, 2000, 11(2) :29.
